Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma

por Lanzi, Cinzia, Favini, Enrica, Dal Bo, Laura, Tortoreto, Monica, Arrighetti, Noemi, Zaffaroni, Nadia, Cassinelli, Giuliana
Publicado 2021

Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma

por Lanzi, Cinzia, Dal Bo, Laura, Favini, Enrica, Tortoreto, Monica, Beretta, Giovanni Luca, Arrighetti, Noemi, Zaffaroni, Nadia, Cassinelli, Giuliana
Publicado 2019

Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases

por Cassinelli, Giuliana, Favini, Enrica, Dal Bo, Laura, Tortoreto, Monica, De Maglie, Marcella, Dagrada, Gianpaolo, Pilotti, Silvana, Zunino, Franco, Zaffaroni, Nadia, Lanzi, Cinzia
Publicado 2016